-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA INC. COMPLETES TRANSFER OF AMELUZ® AND RHODOLED® FDA APPROVAL AND ASSOCIATED INTELLECTUAL PROPERTY PORTFOLIO

Reuters·12/18/2025 13:45:00

Please log in to view news